Playlist

Singer from Turkmenistan Dovran Shammyev will take part in the Silk Way Star contest in Astana

19 Aug. 10:38

Source

Filming of the first Asian vocal competition Silk Way Star, in which performers from 12 countries will take part, begins in Astana on August 20. Turkmenistan will be represented on the project by singer and composer Dovran Shammyev.

The competition consists of 10 episodes. The artists will demonstrate musical traditions and modern trends of the Asian music scene. Viewers can expect joint performances of singers from different countries and their stories. The grand final will be shown live on November 22 on leading TV channels of the participating countries, including Turkmenistan, Orient notes.
The winner will be determined by a system where the votes of the professional jury and the audience will be counted equally - 50% each. The jury includes Turkmen conductor Rasul Klychev.
Dovran Shammyev performs music in the genres of jazz, pop, rock, blues and classical music. He also writes music and is involved in social activities.
The organizers note that Silk Way Star is conceived as an international platform for cultural exchange and dialogue through music. The competition is held within the framework of an agreement between the Presidential Television and Radio Broadcasting Company of Kazakhstan and the China Media Corporation CMG. In the future, the project is planned to be held annually in different Asian countries.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌